Rankings
▼
Calendar
PRTA Q1 2024 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena
PRTA
Prothena Corporation plc
$549M
Q1 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$50,000
-97.7% YoY
Gross Profit
$50,000
100.0% margin
Operating Income
-$82M
-163056.0% margin
Net Income
-$72M
-144478.0% margin
EPS (Diluted)
$-1.34
QoQ Revenue Growth
-84.2%
Cash Flow
Operating Cash Flow
-$73M
Free Cash Flow
-$73M
Stock-Based Comp.
$12M
Balance Sheet
Total Assets
$623M
Total Liabilities
$121M
Stockholders' Equity
$502M
Cash & Equivalents
$547M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$50,000
$2M
-97.7%
Gross Profit
$50,000
-$43M
+100.1%
Operating Income
-$82M
-$56M
-44.7%
Net Income
-$72M
-$47M
-54.1%
Revenue Segments
License
$50,000
100%
← FY 2024
All Quarters
Q2 2024 →